| Year |
Citation |
Score |
| 2019 |
Deyama S, Bang E, Wohleb ES, Li XY, Kato T, Gerhard DM, Dutheil S, Dwyer JM, Taylor SR, Picciotto MR, Duman RS. Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine. The American Journal of Psychiatry. appiajp201817121368. PMID 30606046 DOI: 10.1176/Appi.Ajp.2018.17121368 |
0.712 |
|
| 2016 |
Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology. PMID 27634096 DOI: 10.1016/J.Neuropharm.2016.09.011 |
0.621 |
|
| 2015 |
Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, Duman RS. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiology of Disease. 82: 254-261. PMID 26102021 DOI: 10.1016/J.Nbd.2015.06.012 |
0.66 |
|
| 2015 |
Dwyer JM, Maldonado-Avilés JG, Lepack AE, DiLeone RJ, Duman RS. Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior. Proceedings of the National Academy of Sciences of the United States of America. 112: 6188-93. PMID 25918363 DOI: 10.1073/Pnas.1505289112 |
0.625 |
|
| 2015 |
Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. BDNF release is required for the behavioral actions of ketamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25539510 DOI: 10.1093/Ijnp/Pyu033 |
0.594 |
|
| 2015 |
Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, Duman RS. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors Neurobiology of Disease. 82: 254-261. DOI: 10.1016/j.nbd.2015.06.012 |
0.703 |
|
| 2013 |
Dwyer JM, Lepack AE, Duman RS. mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure. Journal of Molecular Psychiatry. 1: 15. PMID 25408908 DOI: 10.1186/2049-9256-1-15 |
0.583 |
|
| 2013 |
Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2268-77. PMID 23680942 DOI: 10.1038/Npp.2013.128 |
0.618 |
|
| 2013 |
Dwyer JM, Duman RS. Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biological Psychiatry. 73: 1189-98. PMID 23295207 DOI: 10.1016/J.Biopsych.2012.11.011 |
0.646 |
|
| 2013 |
Hughes ZA, Neal SJ, Smith DL, Sukoff Rizzo SJ, Pulicicchio CM, Lotarski S, Lu S, Dwyer JM, Brennan J, Olsen M, Bender CN, Kouranova E, Andree TH, Harrison JE, Whiteside GT, et al. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. Neuropharmacology. 66: 202-14. PMID 22551786 DOI: 10.1016/j.neuropharm.2012.04.007 |
0.411 |
|
| 2012 |
Dwyer JM, Lepack AE, Duman RS. mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 429-34. PMID 22114864 DOI: 10.1017/S1461145711001702 |
0.654 |
|
| 2011 |
Banasr M, Dwyer JM, Duman RS. Cell atrophy and loss in depression: reversal by antidepressant treatment. Current Opinion in Cell Biology. 23: 730-7. PMID 21996102 DOI: 10.1016/J.Ceb.2011.09.002 |
0.569 |
|
| 2011 |
Sukoff Rizzo SJ, Leonard SK, Gilbert A, Dollings P, Smith DL, Zhang MY, Di L, Platt BJ, Neal S, Dwyer JM, Bender CN, Zhang J, Lock T, Kowal D, Kramer A, et al. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise? The Journal of Pharmacology and Experimental Therapeutics. 338: 345-52. PMID 21508084 DOI: 10.1124/Jpet.110.177378 |
0.348 |
|
| 2011 |
Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry. 69: 754-61. PMID 21292242 DOI: 10.1016/J.Biopsych.2010.12.015 |
0.713 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2011 |
Hughes Z, Dwyer J, Pulicicchio C, Rosenzweig-Lipson S, Brandon N, Liu F. P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors European Neuropsychopharmacology. 21: S540-S541. DOI: 10.1016/S0924-977X(11)70879-3 |
0.306 |
|
| 2010 |
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (New York, N.Y.). 329: 959-64. PMID 20724638 DOI: 10.1126/Science.1190287 |
0.712 |
|
| 2010 |
Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, Chan K, Manners MT, Samad TA, Kennedy JD, Bingham B, Whiteside GT. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiology of Disease. 39: 148-55. PMID 20381618 DOI: 10.1016/J.Nbd.2010.03.020 |
0.408 |
|
| 2010 |
Beyer CE, Dwyer JM, Platt BJ, Neal S, Luo B, Ling HP, Lin Q, Mark RJ, Rosenzweig-Lipson S, Schechter LE. Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation. Psychopharmacology. 209: 303-11. PMID 20224888 DOI: 10.1007/s00213-010-1791-1 |
0.364 |
|
| 2010 |
Dwyer JM, Platt BJ, Rizzo SJ, Pulicicchio CM, Wantuch C, Zhang MY, Cummons T, Leventhal L, Bender CN, Zhang J, Kowal D, Lu S, Rajarao SJ, Smith DL, Shilling AD, et al. Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1193-205. PMID 20047711 DOI: 10.1017/S1461145709991088 |
0.321 |
|
| 2010 |
Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, Graf R, Grauer S, Pulicicchio C, Resnick L, Rahman Z, Sukoff Rizzo SJ, Luo B, Beyer CE, Logue SF, Marquis KL, et al. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 58: 69-77. PMID 19615387 DOI: 10.1016/J.Neuropharm.2009.07.016 |
0.399 |
|
| 2008 |
Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ, Malberg JE, Beyer CE, Schechter LE, Rosenzweig-Lipson S, Ring RH. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology. 197: 601-11. PMID 18311561 DOI: 10.1007/S00213-008-1080-4 |
0.668 |
|
| Show low-probability matches. |